This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis.
- Investigator
- Cesar A Trillo-Alvarez
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Research at a glance
Top areas of exploration
- Acute Lung Injury , 2 publications
- Respiratory Distress Syndrome , 2 publications
- Critical Illness , 2 publications
- Anti-Bacterial Agents , 1 publications
Research activity
Active clinical trials
The purpose of this study is to evaluate the safety, and tolerability and efficacy of VX-522 in participants 18 years of age and older with cystic fibrosis and a cystic fibrosis transmembrane conductance regulator (CFTR) genotype not responsive to鈥�
- Investigator
- Cesar A Trillo-Alvarez
- Status
- Accepting Candidates
- Ages
- 18 Years - 64 Years
- Sexes
- All
My publications
Filter publications
11 publications
2009
Evaluation of "Loss" and "End stage renal disease" after acute kidney injury defined by the Risk, Injury, Failure, Loss and ESRD classification in critically ill patients.
Intensive care medicine
鈥�